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Abstract
Cuprizone-induced demyelination is a mouse model of multiple sclerosis (MS) as cuprizone-fed mice
exhibit neuroin-flammation and demyelination in the brain. Upon removal of cuprizone from the
diet, inflammation is resolved and reparative remyelination occurs. In an Affymetrix Gene-Chip
analysis, the stress-associated gene p8 was strongly upregulated (>10×) during cuprizone-induced
demyelination but not remyelination. We verified this upregulation (>15×) of p8 in the CNS during
demyelination by real-time polymerase chain reaction (PCR). This upregulation is brain-specific, as
p8 is not elevated in the liver, lung, kidney, spleen, and heart of cuprizone-treated mice. We also
localized the cellular source of p8 during cuprizone treatment, and further found elevated expression
during embryogenesis but not in normal adult brain. Compared with wild-type controls, the death of
oligodendrocytes in p8−/− mice is delayed, as is microglial recruitment to areas of demyelination.
The corpus callosum of p8−/− mice demyelinates at a slower rate than wild-type mice, suggesting
that p8 exacerbates CNS inflammation and demyelination. Enhanced expression of p8 is also
observed in the spinal cords of mice with acute experimental autoimmune encephalomyelitis (EAE)
induced by PLP139–151 peptide (10×). Increased expression is detected during disease onset and
expression wanes during the remission phase. Finally, p8 is found upregulated (8×) in post-mortem
tissue from MS patients and is higher in the plaque tissue compared with adjacent normal-appearing
white and gray matter. Thus, p8 is an excellent candidate as a novel biomarker of demyelination.
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p8 is a small ubiquitous protein of 80 amino acids identified upon its strong but transient
upregulation in pancreatic acinar cells during experimental acute pancreatitis, development
and regeneration (Mallo et al., 1997). Expression of p8 is upregulated by a wide range of cellular
stressors, including pro-apoptotic agents, lipopolysaccharide, and simply changing culture
media (Jiang et al., 1999; Garcia-Montero et al., 2001). The same molecule was independently
discovered and named candidate of metastasis 1 (com1) in a screen of breast cancer cells and
is highly upregulated and even required for tumor development and progression (Ree et al.,
1999, 2000; Vasseur et al., 2002a,b; Su et al., 2001b). In pancreatic cancer, p8 overexpression
inversely correlated with apoptosis (Su et al., 2001a), suggesting that dying cells are not
expressing p8. Thus, p8 may have pro-survival properties. p8 is likely a DNA-binding protein,
although its DNA-binding capacity is found to be weak, and it has structural characteristics
shared with the high-mobility group (HMG) proteins, thus strongly implicating its role in
transcriptional regulation (Encinar et al., 2001).
The role of p8 in the brain has not been established. p8 mRNA expression in normal rat and
human brain was barely detectable (Mallo et al., 1997; Vasseur et al., 1999). Induction of p8
was not observed in the brain after systemic injection of lipopolysaccharide (LPS) (Jiang et
al., 1999). Recently, the level of p8 was found to correlate with pituitary gland tumor
development, implicating p8 in tumorigenesis of the pituitary gland in the brain (Mohammad
et al., 2004).
During cuprizone-induced demyelination, we discovered a profound upregulation of p8
following inflammation and demyelination in the mouse brain by Affymetrix GeneChip
analysis (Arnett et al., 2003). Cuprizone is a copper chelator that, when given in small doses
(0.2%) in the feed of mice, acts as a neurotoxin that specifically induces the death of
oligodendrocytes and causes inflammation in areas of resulting demyelination (Matsushima
and Morell, 2001). The effect is reversible such that its removal from the diet permits
remyelination and a reduction in inflammation. Thus, cuprizone-induced demyelination
permits analysis of inflammation, demyelination, and remyelination. The lesions that occur in
the brains of cuprizone-treated mice are similar to type III and type IV MS lesions (Lucchinetti
et al., 2000). An advantage of the cuprizone model is the predictability of lesion location. Large
tracts of myelinated fibers, specifically the corpus callosum and the cerebral peduncles, are the
normal target of cuprizone-induced demyelination (Matsushima and Morell, 2001). In this
model, focal inflammation and demyelination occurs in the brain however T lymphocytes do
not play a role (Hiremath et al., 1998; Matsushima and Morell, 2001). RAG-1−/− mice, which
lack T and B cells, respond similarly to wild-type controls upon cuprizone treatment (Arnett
et al., 2001).
We show that the upregulation of p8 is restricted to the brain during cuprizone-induced
demyelination and is not a general response found in other tissues. p8 is primarily upregulated
in microglia, although during the peak of inflammation, it can be found elevated in other cells
as well. CNS-derived p8 upregulation is not limited to the cuprizone model and occurs during
the height of experimental autoimmune encephalomyelitis. Most significantly, p8 is greatly
elevated in multiple sclerosis plaques. Together with a functional analysis of p8 during
inflammatory demyelinating disease using mice lacking the gene, these results suggest that p8
is a strong biomarker candidate for demyelination.
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Mice lacking p8−/− and wild-type control mice (p8+/+) were bred to the C57BL/6 background
(8th generation). All mice were 8–10 weeks of age before the start of cuprizone treatment.
Male p8−/− and p8+/+ mice were fed 0.2% cuprizone [oxalic bis(cyclohexylidenehydrazide)]
(Aldrich, St. Louis, MI) for 2, 3, 3.5, 4, or 5 weeks.
SJL female mice were purchased from Harlan-Sprague-Dawley (Indianapolis, IN). Induction
of experimental autoimmune encephalomyelitis (EAE) was carried out according to standard
protocol at 6–8 weeks of age. Mice were primed subcutaneously with an emulsion containing
100 µl of incomplete Freund’s adjuvant (Difco) supplemented with 200 µg Mycobacterium
tuberculosis H37Ra (Difco, Kansas City, MO) and 100 lg of either PLP139–151
(HSLGKWLGHPDKF) or OVA323–339 (ISQAVHAAHAEI-NEAGR) distributed over three
spots on the flank. Clinical disease was monitored as previously described (McRae et al.,
1995). Three mice were sacrificed at each clinical time point; preclinical (right before onset of
clinical symptoms), peak of acute disease, and remission.
Tissue Preparation and Histopathological Analysis
Brains from cuprizone-treated mice were paraffin embedded, and coronal sections were cut at
the fornix region of the corpus callosum as detailed (Arnett et al., 2001). To examine
myelination, sections were stained by Luxol fast blue-periodic acid Schiff (LFB-PAS; Sigma,
St. Louis, MO). Sections were read by three double-blinded readers and graded on a scale from
0 (complete myelination) to 3 (complete demyelination).
In Situ Hybridization
C57BL/6 mice were perfused with RNase-free phosphate-buffered saline (PBS) and then 4%
PFA. Brains were incubated in fixative until mounted for cryosectioning. Detection of mRNA
for p8 was performed by in situ hybridization as described previously (Schmid et al., 2002).
Expression of p8 and beta-actin were quantitated using NIH Image 1.62 software, and relative
abundance of p8 was determined. For double-labeling experiments, immunohistochemistry
with either GFAP, NeuN, or CNPase antibodies or tomato lectin was performed to identify
astrocytes, neurons, oligodendrocytes or microglia/macrophages respectively.
Immunohistochemistry
Mature oligodendrocytes were detected by the GSTπ primary antibody as described (Plant et
al., 2005). Microglia/macrophages were detected with RCA-1 (Vector) as described.
Tissue and RNA Processing
SJL mice were anesthetized and perfused with PBS. The brains and spinal cords were harvested
and snap frozen on dry ice. They were then stored at −80° C until further processing. Tissue
was homogenized by forcing through a metal screen. Total RNA was isolated using Trizol
according to the manufacturer’s instructions (Invitrogen). RNA was then treated with DNase
I (Invitrogen) to eliminate any DNA contamination.
C57BL/6 mice were lethally anesthetized, and organs (brain, liver, kidney, heart, spleen, lung)
were immediately removed and stored in RNALater until further processing (Qiagen, Valencia,
CA). Total RNA was isolated from a dissected region of C57BL/6 wild-type mouse brains
containing the corpus callosum. RNA isolations were performed using the Qiagen RNeasy kit.
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Frozen postmortem tissue samples were obtained from the Human Brain and Spinal Fluid
Resource Center (Los Angeles, CA). Tissue samples were from the frontal, parietal and
occipital brain regions of three patients previously diagnosed with multiple sclerosis. Normal-
appearing white matter (NAWM), normal-appearing gray matter (NAGM) and an adjacent
plaque were dissected from each region. RNA was isolated using the Qiagen RNeasy kit.
Real-Time Quantitative RT-PCR
TaqMan 5′ nuclease real-time PCR assays were performed using an ABI Prism 7900 sequence-
detection system (PE Applied Biosystems, Foster City, CA) using primers for p8 designed to
span intron–exon junctions to differentiate between cDNA and genomic DNA. Primers and
probe used to detect mouse p8 were as follows: 5′ primer, TTCCCCCACAGTTCTTTTGG;
3′ primer, GGCAAGATGGGAGCAAGAAG; probe, Fam-CTGTCTTCCTAGCTCTG-
CCCGTCTACCC-Tamra. Primers and probe used to detect human p8 were as follows: 5′
primer, CGCTGAGAC-AGAGCTGGAGAT; 3′ primer, GCAAGCCGGCCTGGAT; probe,
Fam-AGGCCAGACCATGGACACTACACCCA-Tamra. Primers and probe for 18S
ribosomal RNA were 5′ primer, GCTGCTGGCACCAGACTT; 3′ primer,
CGGCTACCACATCCAAGG; probe, Fam-CAAATTACCCACTCCCGACCCG-Tamra.
Thermal cycle parameters were optimized to 2 min at 50°C, 2 min at 95°C, and 40 cycles
comprising denaturation at 95°C for 15 s and annealing–extension at 56°C for 1.5 min.
Reactions for 18S were performed alongside p8 during each experiment and used to normalize
for amounts of cDNA.
Isolation of Peritoneal Macrophages and Cell Death Assay
Following CO2 asphyxiation, the peritoneal cavity was flushed with PBS using a 27-gauge
needle. Approximately 7 ml of peritoneal fluid was recovered from each mouse. Peritoneal
lavage fluid from 4 p8−/− and 4 p8+/+ mice were pooled and 75,000 cells/well were plated in
96-well microtiter plates and allowed to adhere overnight. Cells were washed and treated as
indicated in 200 µl of new media. Each treatment was performed in triplicate. After 72 h, 50
µl of serum-free media containing 1 µg/ml XTT and 25 mM phenazine methosulfate was added
to each well. Plates were read at 450 nm after 4 h of incubation. Viability was calculated as
the percentage of color change relative to untreated control. Error bars represent the standard
deviation for each triplicate set.
Statistical Analysis
Unpaired Student’s t-tests were used to statistically evaluate significant differences. Data are
expressed as mean ± SEM.
RESULTS
Upregulation of p8 During Cuprizone-Induced Inflammation and Demyelination
The treatment of C57BL/6 mice with 0.2% cuprizone in the diet induces neuro-inflammation
and demyelination in a predictable time course. Gross demyelination, loss of mature
oligodendrocytes, microglial/macrophage and astrocyte activation and recruitment to areas of
demyelination are observed consistently in the large myelinated fiber tracts, including the
corpus callosum. While these processes begin within 1 week of treatment (Matsushima and
Morell, 2001), significant changes in cell numbers at the corpus callosum are typically not
observed until about 3 weeks (Fig. 1). Microglia and astrocyte recruitment to areas of
demyelination is greatest around weeks 4–5 in wild-type mice. Demyelination is complete and
no mature oligodendrocytes are detected in the corpus callosum after 5 weeks (Fig. 1).
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Using an Affymetrix GeneChip analysis of cuprizonetreated mouse brain tissue (Arnett et al.,
2003), we found p8 upregulated 11-fold over p8 levels in untreated brain (Fig. 2). Real-time
quantitative PCR analysis was performed on cDNA from mouse brain tissue before and after
cuprizone treatment to verify this finding. Compared with untreated brain, p8 was upregulated
about 10× within 1 week of cuprizone treatment and peaked at 3 weeks of treatment (15×) (Fig.
3A). p8 remained elevated at 5 weeks of treatment, and then declined during the remyelination
phase at weeks 6 and 7. As reported, p8 was downregulated on the GeneChip after mice were
returned to a normal diet which allows for remyelination to proceed (Fig. 2), and the real-time
PCR analysis verified these data (Fig. 3). Thus, upregulation of p8 is coincident with the active
inflammatory demyelinating phase and not with remyelination.
To determine whether p8 was upregulated in other body organs during cuprizone treatment,
real-time PCR analysis of p8 in liver, kidney, heart, spleen, and lung tissues was performed.
p8 levels vary widely from organ to organ; however, they remained steady in these tissues
during or after cuprizone treatment (Fig. 3B–F). Thus, p8 upregulation upon cuprizone
treatment is specific to the brain.
Early Developmental p8 Expression
As reports of p8 expression in the brain are minimal, we investigated the presence of p8 in the
brain during development and under normal conditions. Northern blot analysis for p8, and β-
actin as a control, was performed on mRNA from brain and liver tissues from mice at various
ages. In the brain, p8 mRNA levels are high at embryonic day 14 (E14) and highest at E16 and
E18 (Fig. 4A, and quantitation in Fig. 4B). Strikingly, this is the period of greatest programmed
cell death in the embryonic mouse brain where an estimated 50–70% of cortical cells are dying
(Blaschke et al., 1996). In addition, extensive microglial activation occurs during this phase in
the cerebral cortex (Upender and Naegele, 1999). Considering that p8 is often upregulated in
cells undergoing stress, it is possible the cells undergoing programmed cell death and/or the
activated microglia are producing high levels of p8. Following birth, p8 mRNA levels are
barely detectable and stabilize at low levels starting at postnatal day 20 through adulthood.
Interestingly, the level of p8 expression in the CNS is lower than that seen in the adult liver.
In contrast, p8 in the embryonic liver is much lower than p8 levels in the adult liver (Fig. 4).
These data coincide with other reports that p8 levels are very low to undetectable in the rat and
human adult brain but show that brain p8 expression is high during embryogenesis (Mallo et
al., 1997;Vasseur et al., 1999).
Localization of p8 During Inflammation
To localize p8 mRNA expression in the brain, in situ hybridization was performed with an
antisense riboprobe specific for p8 mRNA. The sense p8 probe showed no staining (Fig. 5A,
sense). In the untreated state, it was very difficult to determine the location of p8 expression
as levels were very low (Fig. 5A). A dramatic induction of p8 mRNA is detected by 2 weeks
of cuprizone treatment and the expression seems to be restricted to the hippocampus and corpus
callosum (arrow). By 4 weeks of treatment, very high levels of p8 were expressed throughout
the entire brain demonstrating a dramatic global upregulation of p8 throughout the entire mouse
brain. Interestingly, even though the mice remain on cuprizone for a full 6 weeks, p8
overexpression subsided by 5 weeks and localized more specifically to the corpus callosum
region where most pathology actually occurs (Fig. 5A, arrow). Cuprizone specifically targets
oligodendrocytes in the brain causing massive demyelination in the corpus callosum and other
large myelinated fiber tracts. In addition, a predictable inflammatory response occurs in which
large numbers of microglia, macrophages, and astrocytes enter the corpus callosum
(Matsushima and Morell, 2001;Plant et al., 2005). Considering the extensive trauma that occurs
at the corpus callosum, it is not surprising to find many cells in the corpus callosum expressing
p8. However, the reason that p8 upregulation initiates in the hippocampus is unknown.
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To determine the p8+ cell type in the brain, in situ hybridization was coupled with
immunohistochemistry. Tomato lectin was used to label microglia and macrophages while
antibodies specific for CNPase-labeled oligodendrocytes, GFAP-labeled astrocytes, and
NeuN-labeled neurons. After 2 weeks of cuprizone treatment, lectin-positive microglia/
macrophages were highly positive for p8, while the level of p8 in oligodendrocyte, neurons
and astrocytes was very low (data not shown). At 4 weeks, p8 mRNA was expressed by all
cell types in the brain, but the level of p8 in microglia (Fig. 5B,a,b) was significantly greater
than that in oligodendrocytes (Fig. 5B,c,d) or other cell types (data not shown). We conclude
that p8 is most prominently, but not exclusively, expressed by microglia and macrophages
during cuprizone-induced inflammation and demyelination.
Delay in Demyelination Without p8
To investigate the functional effect of p8 during cuprizone-induced inflammation and
demyelination, we induced demyelination in mice lacking p8. Both p8+/+ and p8−/− mice were
fed 0.2% cuprizone in their diet for 0, 2, 3, 3.5, 4, or 5 weeks before sacrifice. Paraffin brain
sections were stained with LFB-PAS. The extent of demyelination was assessed at midline
corpus callosum at the level of the fornix on a scale from 0 (complete normal myelin) to 3
(complete demyelination). Scores from each individual mouse were plotted (Fig. 6). Although
p8−/− mice showed less overall demyelination compared with wild-type mice at the 2- and 3-
week time points, the differences are not statistically significant. However, after 3.5 weeks of
treatment, wild-type mice displayed significantly more demyelination than did p8−/− mice (P
< 0.0001). By 4 and 5 weeks of cuprizone treatment, almost all mice were fully demyelinated
such that no differences were seen between wild-type and p8−/− mice. Thus, p8 has a significant
but transient role in exacerbating the inflammatory demyelinating process in the brain.
Moderate Delay in Oligodendrocyte Death in p8−/− Mice
To verify the LFB data, immunohistochemistry to detect mature oligodendrocytes was
performed on adjacent paraffin sections using the GSTπ primary antibody. Similar to the LFB
data, 0, 2, or 3-week-treated brains from wild-type and p8−/− mice have similar numbers of
mature oligodendrocytes. After 3.5 weeks of treatment, more GSTπ-positive oligodendrocytes
were present in the corpus callosum of p8−/− mice compared with wild-type mice (P = 0.14)
(Fig. 7A). Mature oligodendrocytes in both strains of mice were almost depleted by 4 weeks
of cuprizone treatment.
Delayed Microglia/Macrophage Recruitment to Corpus Callosum in p8−/− Mice
To explore the possible mechanism accounting for the delay in oligodendrocyte death and
demyelination in the corpus callosum of p8−/− mice, we investigated the effects of p8 on
microglial and macrophage recruitment to the demyelinating region. RCA-1 lectin was used
to mark microglia and peripheral macrophages. Lectin-positive cells at midline corpus
callosum were quantitated in double-blind fashion. Significantly more microglia/macrophages
were found in wild-type mice compared with p8−/− mice (P < 0.04) (Fig. 7B). It is possible
that p8−/− microglia/ macrophages are less responsive to activation and recruitment signals to
areas of demyelination. They may also undergo apoptosis more readily. Alternatively, the
reduced oligodendrocyte cells in p8−/− mice may in turn lessen inflammation and reduce
microglial recruitment.
Apoptosis of Macrophages is Unchanged in p8−/− Mice
To assess whether p8 has any role in apoptosis or cell death, p8−/− and p8+/+ macrophages were
examined for susceptibility to cell death. Peritoneal macrophages were isolated instead of
microglia because the latter are very difficult to isolate from mice. Cells were exposed to a
number of pro-apoptotic stimuli: staurosporine, Taxol, and ultraviolet (UV) irradiation. Cell
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viability was measured 72 h later using the XTT assay. No difference in susceptibility to these
agents was determined, suggesting that p8 is not involved in defense against apoptosis of
macrophages (Fig. 7C). Thus the reduced numbers of p8−/− macrophages at the site of
inflammation and demyelination (Fig. 7B) is not due to enhanced macrophage cell death. Thus,
while we cannot say for certain why p8−/− microglia/macrophages are slower to accumulate
at the corpus callosum, p8−/− microglia and macrophages probably do not have a greater
susceptibility to apoptose during cuprizone-induced demyelination.
Upregulation of p8 in Experimental Autoimmune Encephalomyelitis
To assess whether the dramatic upregulation of microglial p8 seen during cuprizone-induced
demyelination occurs in another model of demyelination, we used the EAE model. This model
is well studied and is a prototype of T-cell-mediated demyelination. SJL mice were treated
with PLP139–151 and adjuvant to induce EAE, then sacrificed at a preclinical time point, at the
peak of disease, or during remission. Real-time PCR analysis was performed using cDNA
generated from these samples. No difference in p8 mRNA levels between control OVA-treated
and PLP139–151-treated mice was found, and no change in p8 levels was found during the
clinical time course of PLP139–151-treated mice (Fig. 8A). In the spinal cord, preclinical
samples also expressed the same amount of p8 as OVA-treated samples. However, a significant
upregulation of p8 (10-fold) was detected at the peak of disease in PLP-treated mice (Fig. 8B).
Levels of p8 mRNA decreased during the remission stage. We believe that the differences in
p8 expression in brain and spinal cord are due to the fact that in EAE, pathology begins in the
caudal spinal cord and gradually moves in the rostral direction with minimal pathology in the
brain (Oldendorf and Towner, 1974;Cross et al., 1993). In addition, the severity of EAE is
typically much greater in the spinal cord than the brain, which could account for the differential
expression of p8 in the spinal cord and brain (Leibowitz and Kennedy, 1972;Simmons et al.,
1982).
Upregulation of p8 in Multiple Sclerosis
To assess the translational relevance of the above findings, we investigated the involvement
of human p8 in MS. Plaque samples from the frontal, parietal, and occipital lobes of each of
three MS patients were used to generate cDNA. Adjacent normal-appearing white matter
(NAWM) and adjacent normal-appearing gray matter (NAGM) were studied. Real-time PCR
analysis revealed a dramatic upregulation of p8 in all plaque tissues tested compared with
NAWM and NAGM (Fig. 9). Although there was significant degree of sample-to-sample
variability, p8 levels were always higher in the plaque tissue than in the adjacent NAWM and
NAGM.
DISCUSSION
As a means to locate novel mediators of demyelination and remyelination, we used an unbiased
cDNA profiling approach to identify genes which exhibit significantly altered expression
during the demyelination and remyelination phases of the cuprizone disease model (Arnett et
al., 2003). Affymetrix array analysis identified p8 as one of the most profoundly affected genes
during the demyelination phase, and this was verified in several ways. First, it is selectively
and profoundly enhanced during demyelination but not during remyelination. Second, during
cuprizone treatment, p8 is selectively enhanced in the brain but not in other tissues. Third, p8
is elevated in brains from cuprizone-treated mice, in the afflicted spinal cords of mice with
EAE and in postmortem human MS plaques. Functional analysis of p8-deficient mice further
confirmed a significant, albeit transitory, role of p8 in enhancing the extent of demyelination.
Thus, this represents the first report linking p8 to the demyelination phase of neurodegenerative
disorders.
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An initial concern is whether p8 upregulation in the brain is simply a nonspecific response to
cuprizone. This is clearly not the case, as other tissues surveyed from cuprizone-treated mice
do not exhibit enhanced p8 expression, although their basal level of p8 expression varied
widely. Furthermore, we have shown that the enhanced expression of p8 occurs in other
relevant instances of demyelination. p8 is elevated 10-fold in the spinal cord of mice at the
peak of symptoms in PLP139–151-induced EAE (Fig. 8B). While this upregulation was found
in the spinal cord and not the brain, this may be due to the lack of significant pathology in the
brains of these mice after treatment. Even more importantly, we found p8 to be elevated in MS
plaques relative to the adjacent normal-appearing white and gray matter (Fig. 9). This was
observed in a variety of plaques found in all lobes of the brain and in both genders from patients
at different ages. With the ability to study the role of p8 in different models of MS, cuprizone-
induced demyelination and EAE, identifying a role for p8 in demyelination may be possible.
As p8 appears to bind DNA and probably acts as a transcription factor, it will be important to
identify the gene targets that are subjected to regulation by p8. Either p8 or its targets may
unveil novel biologic and regulatory processes that may affect the outcome of demyelination.
We next investigated which cell types express p8 and how p8 upregulation may affect the
course of demyelination. In situ hybridization during early treatment demonstrates a relatively
restricted upregulation of p8 that could be attributed to the microglial population (week 2).
However, by 4 weeks of cuprizone treatment, there is a dramatic upregulation of p8 throughout
the entire brain. While microglia/macrophages clearly express p8 at a very high level at 4
weeks, it appears that p8 is widely expressed by oligodendrocytes, astrocytes and neurons as
well, but at a significantly lower level. In the cuprizone model, this is the time point when many
of the mature oligodendrocytes are dead or dying, yet concomitantly oligodendrocyte
progenitors are increasing in number, and microglia/macrophages and astrocytes are highly
activated and recruited to areas of demyelination (Matsushima and Morell, 2001) (Fig. 1). This
corresponds with a previous finding that the overexpression of p8 accompanied and enhanced
cellular proliferation (Vasseur et al., 1999). Indeed, the analysis of mice deficient in p8 show
that microglial/macrophage accumulation at the demyelination site appears to be significantly
reduced by the absence of p8 (Fig. 7B). The reduced microglial accumulation likely contributes
to a decrease in the overall inflammatory environment and in the loss of oligodendrocytes.
Currently, the link, if any, between the upregulation of p8 in numerous types of human cancers
and its upregulation during demyelination is unclear (Ree et al., 2000; Su et al., 2001b). It has
been noted that the development of metastasis in target organs correlated with p8 expression
(Ree et al., 1999). Tumor establishment through the introduction of the rasV12 mutated protein
and the E1A do not occur in embryonic fibroblasts derived from mice lacking p8 (Vasseur et
al., 2002a), suggesting the requirement of p8 for the development of cancer. It has been
hypothesized that p8 expression in cancer is simply a response to the stressful environment
engendered by metastatic cancer (Iovanna, 2002). In addition to tumor-induced stress, simply
changing the culture media of cells induced upregulation of p8 as did exposure to
lipopolysaccharide and pro-apoptotic agents (Jiang et al., 1999; Garcia-Montero et al., 2001).
By extension to the CNS, while p8 expression is not significant in normal adult brain tissues,
p8 is induced in the embryonic mouse brain during development, correlating with the period
of massive programmed cell death and growth. In an inflammatory, demyelinating adult brain,
cells are exposed to an unusual environment that may induce a stress response causing p8
induction.
In summary, this report is the first to show a selective enhancement of p8 in the affected brains
of different demyelination models and of humans afflicted with MS. Functional analysis shows
that p8 expression can exacerbate the extent of demyelination, cause an enhanced presence of
microglial cells and a concomitant decrease in oligodendrocytes. The brain-specific elevation
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of p8, as well as its enhancement during demyelination, suggests that p8 may serve as a marker
for neuroinflammation and/or demyelination.
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Time course of cuprizone-induced inflammation and demyelination. In an untreated state (left
column), the corpus callosum is fully myelinated as assessed by LFB-PAS staining and
GSTπ+ mature oligodendrocytes are abundant. Very few to no GFAπ+ astrocytes and
lectin+microglia/macrophages are detected in this region. After 3 weeks of cuprizone treatment
(second column), significant demyelination occurs in the corpus callosum. Significant
oligodendrocyte loss occurs by 3 weeks, while astrocytes and microglia begin to populate this
area. After 5 weeks of cuprizone treatment, the corpus callosum is devoid of myelinated axons,
and no GSTπ+mature oligodendrocytes are detected. Astrogliosis and microglial/macrophage
infiltration becomes more prominent between 3 and 5 weeks.
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Upregulation of p8 during cuprizone-induced demyelination. Affymetrix GeneChip analysis
shows that p8 expression was increased 11X following 5 weeks of cuprizone treatment when
compared with the untreated brain. One week after removal of cuprizone from the diet of mice
(7 weeks), remyelination occurs, and p8 levels returned to baseline.
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Cuprizone-induced p8 upregulation is restricted to brain tissues. Real-time PCR analysis of p8
mRNA levels in tissue following 1, 3, 5, or 6 weeks of cuprizone treatment was performed.
The 7-week time point is 1 week after removal of cuprizone from the diet. Data were
standardized to 18S and is expressed as fold change over the untreated state. A: Brain was the
only location where p8 was upregulated during cuprizone treatment. p8 mRNA reverted to
pretreatment levels by 7 weeks. Levels of p8 mRNA in the kidney (B), liver (C), spleen (D),
lung (E), and heart (F) remained similar to the untreated state at all time points. Each bar is
the average of three mice.
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Northern blot analysis of p8 in embryonic and postnatal brain and liver. A: Levels of p8 were
highest in embryonic days 14–18 brain, downregulated at birth, and expressed at a low but
detectable level in the adult CNS. B: Expression of p8 and beta-actin (data not shown) were
quantitated using NIH Image 1.62 software, and relative abundance of p8 was determined.
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Localization of p8 in cuprizone treated brain. In situ hybridization analysis coupled with
immunohistochemistry was performed on untreated and cuprizone treated brains. A: Whole
brain images demonstrate the temporal differences in p8 expression over the course of
cuprizone treatment. Sections hybridized with the sense p8 probe show no staining (sense). All
other brain sections were labeled with the p8 antisense riboprobe. B: Biotinylated tomato lectin
(a,b) was used to label microglia and macrophages in the corpus callosum after 4 weeks of
cuprizone treatment. CNPase-specific antibodies were used to label oligodendrocytes (c,d) in
the hippocampus after 4 weeks of cuprizone treatment. All cell types were visualized in brown.
p8 expression was detected using 33P-labeled riboprobes and visualized as black grains in
photoemulsion. a,b: Two focal planes of the same tissue section. a: Focus on the level of the
grains in the photoemulsion while in panel b, the focus is on the level of lectin-positive
microglia. These panels demonstrate p8 co-localizes with lectin-positive microglia (arrows).
c,d: Two focal planes of the same tissue section. c: Focus on the level of the grains in the
photoemulsion. d: In contrast, focus is on the level of the CNPase immunohistochemistry.
There was very little colocalization of p8 and CNPase.
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Delay in demyelination in p8−/− mice. LFB stained brain sections from p8−/− and wild-type
mice were graded on a scale from 0 (complete myelination) to 3 (complete demyelination) by
3 double-blinded investigators. White circles represent p8−/− mice and black circles represent
wild-type mice. Horizontal lines represent the median in each group. A significant delay in
demyelination in p8−/− mice is found at the 3.5-week time point. The toxicity of cuprizone
treatment results in complete demyelination in all mice by 4–5 weeks of cuprizone treatment.
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Reduced numbers of mature oligodendrocytes and less CNS microglial/macrophage
infiltration in p8−/− mice. A. GSTπ immunohistochemistry was performed on paraffin sections
from untreated and 2-, 3-, 3.5-, and 4-week treated brain. GSTπ+ cells at midline corpus
callosum were quantitated. No differences in the numbers of oligodendrocytes in the untreated
state or after 2 or 3 weeks of cuprizone treatment were observed. Less oligodendrocytes are
found in wild-type mice compared with p8−/− mice after 3.5 weeks of treatment, although not
statistically significant. By week 4, almost no oligodendrocytes are detected in the corpus
callosum in either p8−/− or wild-type mice. B. Paraffin brain sections from wild-type and
p8−/− mice treated for 3.5 weeks were stained with RCA-1 lectin. RCA+ cells at midline corpus
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callosum were quantitated. Significantly fewer microglia/macrophages were found in the
p8−/− mice (P < 0.04). C: Absence of p8 does not affect cell viability in response to a variety
of apoptotic stimuli. Peritoneal macrophages were isolated from p8−/− or wild-type control
mice. After 12 h, the media was replaced with media containing the indicated concentrations
of staurosporine or Taxol. As an additional treatment, one set of wells was exposed to UV
radiation for 10 min. Cell viability was measured 72 h later using the XTT assay. No significant
difference in death was observed between control and p8−/−macrophages.
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p8 upregulation in experimental autoimmune encephalomyelitis. Wild-type SJL mice were
immunized with OVA or PLP139–151 and adjuvant. Immunized mice were sacrificed at one of
three clinical time points. Brain and spinal cords were removed for real-time PCR analysis of
p8 mRNA levels. A: p8 mRNA levels in the brains of PLP139–151 immunized mice did not
change over the clinical time course, nor were they different from p8 levels in the brains of
OVA immunized mice. B: p8 mRNA levels in the spinal cords of PLP139–151 immunized mice
were not different from OVA immunized mice at the preclinical stage. However, a significant
increase in p8 was found in the spinal cord at the peak of EAE in PLP139–151 immunized mice.
In the clinically defined remission stage, p8 levels fall but remain elevated above the preclinical
state.
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Upregulation of p8 in multiple sclerosis plaques. Real-time PCR analysis was performed on
cDNA generated from postmortem brain tissue from MS patients. Normal-appearing white
matter (NAWM) and normal-appearing gray matter (NAGM), found adjacent to plaques, were
analyzed. Compared with NAWM, the p8 mRNA levels in plaques were significantly elevated,
while NAGM was not different from NAWM.
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